Koji Nakao
Director/Board Member bei JEOL LTD.
Profil
Koji Nakao currently works at Nanotis Corp., as Chairman from 2011 and JEOL Ltd., as Independent Outside Director from 2018.
Mr. Nakao also formerly worked at Terumo Corp., as Chairman.
Mr. Nakao received his graduate degree in 1970 from Keio University.
Aktive Positionen von Koji Nakao
| Unternehmen | Position | Beginn |
|---|---|---|
| JEOL LTD. | Director/Board Member | 01.06.2018 |
Nanotis Corp.
 Nanotis Corp. Medical SpecialtiesHealth Technology Nanotis Corp. engages in the research and development of rapid diagnostic devices. It plans to expand its technology through micro-chips and smartphones for the testing of SARS, MERS, Zika fever, dengue fever, and other infectious diseases. The company was founded by Lisa Sakashita and Michika Onoda on June 6, 2016 and is headquartered in Shibuya, Japan. | Chairman | 01.01.2011 |
Ehemalige bekannte Positionen von Koji Nakao
| Unternehmen | Position | Ende |
|---|---|---|
| TERUMO CORPORATION | Chairman | - |
Ausbildung von Koji Nakao
| Keio University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TERUMO CORPORATION | Health Technology |
| JEOL LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Nanotis Corp.
Nanotis Corp. Medical SpecialtiesHealth Technology Nanotis Corp. engages in the research and development of rapid diagnostic devices. It plans to expand its technology through micro-chips and smartphones for the testing of SARS, MERS, Zika fever, dengue fever, and other infectious diseases. The company was founded by Lisa Sakashita and Michika Onoda on June 6, 2016 and is headquartered in Shibuya, Japan. | Health Technology |
